Tuesday, March 18, 2025 | 12:55 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

ERIS Lifesciences consolidated net profit rises 8.66% in the September 2019 quarter

Image

Capital Market

Sales rise 7.64% to Rs 280.46 crore

Net profit of ERIS Lifesciences rose 8.66% to Rs 92.71 crore in the quarter ended September 2019 as against Rs 85.32 crore during the previous quarter ended September 2018. Sales rose 7.64% to Rs 280.46 crore in the quarter ended September 2019 as against Rs 260.56 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales280.46260.56 8 OPM %39.1738.64 -PBDT114.50100.59 14 PBT102.7792.31 11 NP92.7185.32 9

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 08 2019 | 11:22 AM IST

Explore News